Dose-response effects of exercise on abdominal obesity and risk factors for cardiovascular disease (CVD) in women and men

Queen's University (Canada)0 个研究点目标入组 320 人开始时间: 2010年2月11日最近更新: 2019年4月8日

适应症

试验速览

•1. Men and women between 40 and 60 years of age. The lower age range for men and women is selected to help ensure recruitment of a sample with metabolic syndrome as prevalence of metabolic syndrome is significantly related to age. The selection of 60 years for the upper age range reflects concerns we have randomising older adults to the high intensity exercise group wherein exercise at 75 - 80% of maximum may be difficult to achieve, and likely to be associated with increased orthopaedic injury and thus, poor compliance. We also considered lowering the lower age range from 40 to 35 years, but decided against doing so to increase the cost-effectiveness of recruitment (e.g., ensure a higher yield of those with metabolic syndrome)
•2. Abdominally obese (waist circumference greater than 88 and 102 cm for women and men respectively) and National Cholesterol Education Program, Adult Treatment Panel III (NCEP-ATPIII) defined metabolic syndrome. Abdominal obesity for non-Caucasians will be determined using values suggested by the International Diabetes Federation.
•3. Sedentary lifestyle (planned physical activity for the purpose of health one day per week or less)
•4. Weight stable (± 2 kg) for 6 months prior to the beginning of the study
•5. Body mass index (BMI) less than 40 kg/m^2 (because a lifestyle-based intervention alone for obesity reduction is ideal for persons with a BMI less than 40 kg/m^2)

•1. Physical impairment which would make the intervention very difficult, or unsafe according to the patient's physician including history of myocardial infarction, stroke, coronary bypass surgery or angioplasty in the last 6 months; peripheral artery disease, unstable angina or ischaemia
•2. Diabetes
•3. Current smokers
•4. Alcohol consumption greater than 21 drinks per week
•5. Plans to move from the area
•6. Participating in another research study
•7. Clinically judged to be unsuitable for participation or adherence as determined by the participants physician
•8. Inability or unwillingness to provide informed consent
•9. For women, planned pregnancy in the next year

发起方

Queen's University (Canada)